Add to ORKG# The Author(s) 2014. This article is published with open access at Springerlink.com Introduction GnRH (gonadotropin-releasing hormone) ana-logues are long-term known to be safe and effective in the clinical management of hormone-dependent advanced pros-tate cancer. However, their unusual mechanism of action of de-sensitizing pituitary receptors makes generic market entr
Prostate cancer is one of the most common cancers in men, predominantly in developed countries. Curr...
Gonadotropin-releasing hormone agonists (GnRH) play an important role in the treatment of prostate c...
ABSTRACT. \u2013 Prostate cancer is androgen-dependent in its initial phase. GnRH agonists, through ...
Castration remains the mainstay of treatment in the management of metastatic prostate cancer. Medica...
Prostate cancer is the second most common cause of cancer-related deaths in men, representing a majo...
Pituitary Gonadotropin-Releasing Hormone receptors (GnRH-R) mediate the activity of the hypothalamic...
Androgen deprivation therapy (ADT) is the main treatment approach in advanced prostate cancer and in...
Objectives: To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists com...
Gonadotropin-Releasing Hormone (GnRH) is the hypothalamic decapeptide which plays a key role in the...
Prostate cancer is androgen-dependent in its early stages and androgen deprivation therapy represent...
Medical castration using gonadotropin-releasing hormone (GnRH) receptor agonists currently provides ...
Objectives To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists comp...
PURPOSE: Comparing gonadotrophin-releasing hormone (GnRH) antagonists and agonists as androgen depri...
It is now well established that hormonal pathways are involved in the development of prostate cancer...
Gonadotropin-releasing hormone analogue (GnRHa) therapy is an established method of androgen withdra...
Prostate cancer is one of the most common cancers in men, predominantly in developed countries. Curr...
Gonadotropin-releasing hormone agonists (GnRH) play an important role in the treatment of prostate c...
ABSTRACT. \u2013 Prostate cancer is androgen-dependent in its initial phase. GnRH agonists, through ...
Castration remains the mainstay of treatment in the management of metastatic prostate cancer. Medica...
Prostate cancer is the second most common cause of cancer-related deaths in men, representing a majo...
Pituitary Gonadotropin-Releasing Hormone receptors (GnRH-R) mediate the activity of the hypothalamic...
Androgen deprivation therapy (ADT) is the main treatment approach in advanced prostate cancer and in...
Objectives: To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists com...
Gonadotropin-Releasing Hormone (GnRH) is the hypothalamic decapeptide which plays a key role in the...
Prostate cancer is androgen-dependent in its early stages and androgen deprivation therapy represent...
Medical castration using gonadotropin-releasing hormone (GnRH) receptor agonists currently provides ...
Objectives To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists comp...
PURPOSE: Comparing gonadotrophin-releasing hormone (GnRH) antagonists and agonists as androgen depri...
It is now well established that hormonal pathways are involved in the development of prostate cancer...
Gonadotropin-releasing hormone analogue (GnRHa) therapy is an established method of androgen withdra...
Prostate cancer is one of the most common cancers in men, predominantly in developed countries. Curr...
Gonadotropin-releasing hormone agonists (GnRH) play an important role in the treatment of prostate c...
ABSTRACT. \u2013 Prostate cancer is androgen-dependent in its initial phase. GnRH agonists, through ...